Home News Research Institutions

Research Institutions

Finnish Scientists Find Brain Cells Involved in Alzheimer’s Disease

New Delhi, December 01, 2017: Alzheimer’s disease is rapidly increasing in prevalence but we have no effective treatment. But, Finnish Researchers have found a new target to investigate. Researchers at the University of East Finland have found that astrocytes, the cells that support...

New release of glioblastoma atlas sheds light on deadly disease

New Delhi, May 16, 2015 Robust new data added to the Ivy Glioblastoma Atlas Project (Ivy GAP) changes the scope and impact of this publicly available resource for researchers and clinicians searching for treatments for this most deadly and...

Vikram Patel, Co-Director of the Centre for Control of Chronic Conditions at PHFI, named...

A psychiatrist and professor of International Mental Health, Prof. Patel led research has played a central role in the development of the field of global mental health and improved care for those with mental disorders in resource-poor...

Minister of State for HRD Dr Shashi Tharoor Urges Corporate Sector to Fund R&D...

New Delhi November 14, 2013: Dr. Shashi Tharoor, Minister of State for HRD urged the Indian private sector to come forward in a big way to fund research and development programmes of Indian universities. He said this while addressing...

Medical Entrance Examination AIPGMEE 2014

New Delhi October 25, 2013: National Board of Examinations will conduct All India Post Graduate Medical Entrance Examination (AIPGMEE) for admission All India 50% quota of MD/MS/PG Diploma courses (2014 session) offered at Government Medical Colleges /Institutions except...

Centers for Disease Control Grant for Manipal University

Bangalore, August 20, 2013: Manipal Centre for Virus Research (MCVR), a research department of Manipal University has been awarded the Research Cooperative Agreement Grant worth USD 1.143 million by the Centers for Disease Control and Prevention (CDC), United State Department...

NürnbergMesse Brazil celebrates the success achieved by FCE Pharma and FCE Cosmetique

Mumbai July 22, 2013: The 18th FCE Pharma and FCE Cosmetique, organized by NürnbergMesse Brasil from May 14-16, at the Transamerica Expo Center, have once again established themselves as the perfect environment for the generation of new businesses and...

Mumbai’s Jaslok Hospital Opts for Napier EHRm Solution

Singapore, Thursday, May 02, 2013 -- (Business Wire India) -- -- Jaslok, one of the most reputed hospitals in Mumbai, will adopt Napier's next generation mobile electronic health records platform that will empower over 1,100 users from the hospital to render faster, more efficient services to its patients.

Napier Healthcare Solutions, a leading healthcare software provider, is pleased to announce that Jaslok Hospital of Mumbai has selected the Napier HER m (pronounced EHR mobile) management suite of products for its end-to-end hospital management needs.

The fully mobile-enabled solution is Napier's next-generation platform that helps deliver the vision of a Digital Hospital. The Napier EHR m is an open-source based platform; when fully deployed in the course of the next few months, it will be used by over 1,100 users from the hospital.

Catalent Biologics Expands into ADCs Through Exclusive License with Redwood Bioscience SMARTagT Advanced Conjugation...

Somerset, New Jersey, United States, Thursday, April 11, 2013 -- (Business Wire India) --

Catalent Pharma Solutions has announced that it has acquired an exclusive license to market Redwood Bioscience's proprietary SMARTag T precision protein-chemical engineering technology for the development of advanced antibody-drug conjugates (ADCs). Redwood's novel, site-specific protein modification and linker technologies enable the generation of homogenous bioconjugates engineered to enhance potency, safety and stability. Combined with Catalent's proprietary GPEx ® cell line expression system, its brand new state-of-the-art biomanufacturing Center of Excellence in Madison, Wisconsin and broad range of bioanalytical and fill-finish services, this deal marks a further expansion of Catalent's capabilities to help customers develop more and better biologic treatments.

Biocon Enhances Partnership with Mylan through Strategic Collaboration for Insulin Products

Bangalore, Karnataka, India, Thursday, February 14, 2013 -- (Business Wire India) -- Biocon, Asia's premier biotechnology company today announced that it has entered into a definitive agreement with Mylan for an exclusive strategic collaboration for the global development and commercialization of generic versions of its three insulin analog products.